Icahn School of Medicine at Mount Sinai at ASHG 2026
New York, New York
Icahn School of Medicine at Mount Sinai at ASHG 2026 in Montréal: 32 presentations (23 posters, 5 platform talks, 3 featured symposia); 20 research groups.
Develops computational methods for genomic, electronic health record, biobank and whole-genome sequencing data. Uses them for equitable risk prediction, rare-disease discovery and clinical genomic care.
65 papers since 2024
›
Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants
Science, 2025
Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations
Nature Medicine, 2024
Author Correction: A genomic mutational constraint map using variation in 76,156 human genomes
Generates single-nucleus RNA-seq, ATAC-seq, ChIP-seq and Hi-C data in human brain tissue. Studies schizophrenia, bipolar disorder and Alzheimer’s disease.
102 papers since 2024
›
Genomics yields biological and phenotypic insights into bipolar disorder
Nature, 2025
Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program
Science, 2024
Single-cell genomics and regulatory networks for 388 human brains
Analyzes multi-omics, RNA-seq, whole-genome sequencing, EHR and brain-imaging data with network models. Uses these data to study disease progression, mechanisms and therapeutic targets.
54 papers since 2024
›
Sex Differences in Long COVID
JAMA Network Open, 2025
Persistent complement dysregulation with signs of thromboinflammation in active Long Covid
Science, 2024
2024 Update of the RECOVER-Adult Long COVID Research Index
Works across genomics, bulk and single-cell RNA seq, proteomics and deep multi-omics profiling of immune cells. Studies Alzheimer’s, Parkinson’s disease and ALS.
52 papers since 2024
›
Single-cell genomics and regulatory networks for 388 human brains
Science, 2024
Single-cell multi-cohort dissection of the schizophrenia transcriptome
Science, 2024
A data-driven single-cell and spatial transcriptomic map of the human prefrontal cortex
Develops statistical-genetics and machine-learning methods on biobank-scale genomic cohorts, DNA-Seq, proteomics and multi-omics data. Uses them to predict disease risk, treatment response and drug targets.
57 papers since 2024
›
A clinical benchmark of public self-supervised pathology foundation models
Nature Communications, 2025
Machine learning–based penetrance of genetic variants
Science, 2025
Machine learning models identify predictive features of patient mortality across dementia types
Integrates bulk expression, DNA methylation, proteomics, single-cell expression and biobanks with computational models. Studies immune-disease risk using Mount Sinai, UK Biobank and All of Us.
16 papers since 2024
›
Clinical Manifestations of VEXAS Syndrome Across a Broad Spectrum of UBA1 Mutation Burden
Arthritis & Rheumatology, 2025
High-dimensional phenotyping to define the genetic basis of cellular morphology
Nature Communications, 2024
Paired analysis of host and pathogen genomes identifies determinants of human tuberculosis
exome and genome sequencing, bulk expression, DNA methylation, proteomics, single-cell expression
Techniques
large-scale genetic association studies, somatic variant detection, colocalization, Mendelian randomization, viral exposure history profiling, ex vivo antiviral pathway activation
Applies AI to electronic health records, genomic sequencing and real-time clinical data streams. Supports diagnosis, drug discovery and personalized care across Mount Sinai Health System.
Funded by Canadian Institutes of Health Research
›
Canadian Institutes of Health Research, Banting Fellowship · 2010
Electronic health records linked to DNA samples, Whole-exome sequencing, Exome-chip genotyping, Mount Sinai Data Warehouse, Real-time streaming clinical data platform, Large supercomputers
Techniques
Machine learning and AI, PheWAS, Admixture analysis and PCA, Gene burden analysis, Natural language processing, Random Forest classification
Analyzes pediatric electrocardiogram, cardiac CT and CMR data with AI. Targets child-health diagnostics and care delivery under Mindich Child Health and Development Institute.
127 papers since 2024
›
Sociodemographic biases in medical decision making by large language models
Nature Medicine, 2025
A foundation model for clinician-centered drug repurposing
Nature Medicine, 2024
Large Language Models Are Poor Medical Coders — Benchmarking of Medical Code Querying
Analyzes genomic SNP, copy number variation, DNA/RNA sequencing, EHR and biobank phenotype data. Studies complex traits, substance-use disorders and sex differences with PsycheMERGE and PGC.
73 papers since 2024
›
Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder
Nature Genetics, 2024
Multi-ancestry genome-wide association study of major depression aids locus discovery, fine mapping, gene prioritization and causal inference
Nature Genetics, 2024
Systems biology dissection of PTSD and MDD across brain regions, cell types, and blood
Models RASopathies and heart defects with iPSCs; analyzes whole-exome, whole-genome, RNA-seq and DNA-methylation data. Studies congenital-heart-defect outcomes through the Pediatric Cardiac Genomics Consortium.
68 papers since 2024
›
Sequencing in over 50,000 cases identifies coding and structural variation underlying atrial fibrillation risk
Nature Genetics, 2025
Functional dissection of human cardiac enhancers and noncoding de novo variants in congenital heart disease
Nature Genetics, 2024
The BabySeq Project: A clinical trial of genome sequencing in a diverse cohort of infants
Uses health systems data, health systems based biobanks, and genetic, clinical, and lifestyle data. Applies genomic discovery to screening, risk prediction, and routine clinical care.
65 papers since 2024
›
Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants
Science, 2025
Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations
Nature Medicine, 2024
Author Correction: A genomic mutational constraint map using variation in 76,156 human genomes
Analyzes gene expression, SNPs, methylation and microRNA data from population studies and placentas. Develops biomarkers for cancer, birth outcomes and child neurodevelopment.
180 papers since 2024
›
Shock or empowerment? Artificial intelligence technology and corporate ESG performance
Economic Analysis and Policy, 2024
Biodegradable piezoelectric polymer for cartilage remodeling
Matter, 2024
Ground-Based Mobile Measurements to Track Urban Methane Emissions from Natural Gas in 12 Cities across Eight Countries
The NIH's standard multi-year research project grant.
“Her lab has recently been awarded an R01 from NIH to establish an atlas for human placenta.”
NIEHS, Center on Health and Environment Across the LifeSpan (HEALS) · active
“She is a member of the Mount Sinai Institute for Exposomic Research and its NIEHS-funded Center on Health and Environment Across the LifeSpan (HEALS).”
Develops statistical genomics methods for whole-genome, whole-exome, RNA-seq and biobank data. Applies them to rare diseases, neurodevelopmental disorders and platelet traits.
29 papers since 2024
›
Mutations in the small nuclear RNA gene RNU2-2 cause a severe neurodevelopmental disorder with prominent epilepsy
Nature Genetics, 2025
Mutations in the U4 snRNA gene RNU4-2 cause one of the most prevalent monogenic neurodevelopmental disorders
Nature Medicine, 2024
Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings
Rare-disease genetic association inference, Gene-expression and splicing modeling, Statistical integration of genetic and omics data, Platelet activation and clot-formation quantification
Integrates exome/WGS, short- and long-read RNA-seq, epigenetic and clinical data. Studies autism, epilepsy, schizophrenia and intellectual disability with Mount Sinai clinical teams.
31 papers since 2024
›
Mapping the genetic landscape across 14 psychiatric disorders
Nature, 2025
Single-cell genomics and regulatory networks for 388 human brains
Science, 2024
Single-cell multi-cohort dissection of the schizophrenia transcriptome